Cocrystal Pharma Inc (COCP)
1.860
+0.13
(+7.51%)
USD |
NASDAQ |
Nov 04, 16:00
1.83
-0.03
(-1.61%)
Pre-Market: 09:03
Cocrystal Pharma Cash from Financing (Quarterly): 0.00 for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 4.00M |
| March 31, 2023 | -0.007M |
| December 31, 2022 | -0.007M |
| September 30, 2022 | -0.007M |
| June 30, 2022 | -0.007M |
| March 31, 2022 | -0.006M |
| December 31, 2021 | -0.009M |
| September 30, 2021 | -0.011M |
| June 30, 2021 | 36.42M |
| March 31, 2021 | 2.063M |
| December 31, 2020 | 3.611M |
| September 30, 2020 | 15.55M |
| June 30, 2020 | -0.044M |
| March 31, 2020 | 16.55M |
| December 31, 2019 | 2.655M |
| September 30, 2019 | -0.042M |
| June 30, 2019 | -0.065M |
| March 31, 2019 | 3.876M |
| December 31, 2018 | 0.024M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 7.685M |
| Date | Value |
|---|---|
| March 31, 2018 | 1.184M |
| December 31, 2017 | 1.00M |
| September 30, 2017 | 0.08M |
| June 30, 2017 | 3.00M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 4.009M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 5.007M |
| December 31, 2015 | 0.003M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 4.05M |
| March 31, 2015 | 11.83M |
| December 31, 2014 | 0.001M |
| September 30, 2014 | 0.058M |
| June 30, 2014 | 0.038M |
| March 31, 2014 | 2.769M |
| December 31, 2013 | 0.002M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.001M |
| March 31, 2013 | 0.004M |
| December 31, 2012 | 0.0906M |
| September 30, 2012 | -0.4503M |
| June 30, 2012 | 0.2349M |
| March 31, 2012 | 1.839M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.044M
Minimum
Jun 2020
36.42M
Maximum
Jun 2021
4.250M
Average
--
Median
Sep 2023
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 122.08M |
| Alaunos Therapeutics Inc | 0.00 |
| Oragenics Inc | 0.8212M |
| Cara Therapeutics Inc | -0.61M |
| Jaguar Health Inc | 12.57M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.699M |
| Free Cash Flow | -14.28M |
| Free Cash Flow Per Share (Quarterly) | -0.3636 |
| Free Cash Flow Yield | -75.40% |